Recruiting Breast Cancer Studies in Ramat Gan
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Researchers are looking for other ways to treat breast cancer (BC) that is hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) and either unresectable locally a...
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Researchers want to learn if patritumab deruxtecan (MK-1022) can treat certain breast cancers. The breast cancers being studied are HER2 positive unresectable locally advanced or metastatic (the cance...
About Breast Cancer Clinical Trials in Ramat Gan
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Ramat Gan, . These studies are seeking a combined 1,081 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Ramat Gan — FAQ
Are there breast cancer clinical trials in Ramat Gan?
Yes, there are 2 breast cancer clinical trials currently recruiting in Ramat Gan, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ramat Gan?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ramat Gan research site will contact you about next steps.
Are clinical trials in Ramat Gan free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ramat Gan studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Ramat Gan are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov